Matthew J. Friedman and the VA National PTSD Brain Bank: New Transcriptomic Insight into PTSD Pathophysiology

Click to increase image sizeClick to decrease image size

Acknowledgments

The author acknowledges the advice and support of his colleagues, both named and unnamed in this article. In particular, Drs Matthew Friedman and Robert Ursano provided important mentoring for those fortunate researchers working with them to develop the NPTSDBB. This work was supported with resources and use of facilities at the Central Texas Veterans Health Care System, Temple, TX. The views expressed here are those of the author and do not necessarily reflect the position or policy of the Department of Veterans Affairs (VA) or the U.S. government.

DISCLOSURE STATEMENT

No potential conflict of interest was reported by the author.

DATA AVAILABILITY STATEMENT

Datasets used in this commentary are available online or from the lead author of the primary publications (Girgenti et al., 2021; Logue et al., 2021).

Additional information

Notes on contributors

Keith A. Young

Keith A. Young is Professor of Psychiatry and Behavioral Sciences at Texas A&M College of Medicine and a Research Pharmacologist at the Central Texas Veterans Health Care System. He has applied stereological techniques to the challenging study of postmortem human brains to investigate genetic and other factors contributing to Alzheimer’s, schizophrenia, mood disorders, and PTSD. He is Senior Advisor to the VA National PTSD Brain Bank and a member of Tissue Access Committee of the Simons Foundation Autism BrainNet Brain Bank, whose tissue has been distributing to over 400 researchers world-wide. Ongoing PTSD and MDD studies in blood and brain include anatomical, spatial spectroscopy, gene expression, gene methylation, microRNA sequencing and genotyping studies.